Invitae

NVTA NYSE
24.22
-0.56
-2.26%
Closed 18:31 07/19 EDT
Open
24.78
Prev Close
24.78
High
24.96
Low
24.04
Volume
1.57M
Avg Vol (3M)
1.74M
52 Week High
26.77
52 Week Low
7.73
% Turnover
1.75%
Market Cap
2.18B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Invitae NVTA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders and other hereditary conditions. The Company offers panels for a range of hereditary conditions in cancer, cardiology, neuromuscular, pediatric and rare diseases. The Company focuses on genetic testing, genome network and genome management. The Company offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. The Company holds interests in AltaVoice, a patient-centered data company.
MORE >

Recently

Name
Price
%Change